-
Something wrong with this record ?
Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation
J. Snášel, I. Machová, V. Šolínová, V. Kašička, M. Krečmerová, I. Pichová
Language English Country Switzerland
Document type Comparative Study, Journal Article
Grant support
CZ.02.1.01/0.0/16_019/000729
Ministerstvo Školství, Mládeže a Tělovýchovy
RVO 61388963
Akademie Věd České Republiky
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
33540748
DOI
10.3390/ijms22031483
Knihovny.cz E-resources
- MeSH
- Adenosine Diphosphate metabolism pharmacology MeSH
- Adenosine Triphosphate metabolism pharmacology MeSH
- Allosteric Regulation MeSH
- Bacterial Proteins antagonists & inhibitors metabolism MeSH
- Enzyme Induction MeSH
- Phosphofructokinases antagonists & inhibitors metabolism MeSH
- Fructosediphosphates biosynthesis pharmacology MeSH
- Fructosephosphates metabolism pharmacology MeSH
- Gluconeogenesis MeSH
- Glycolysis MeSH
- Hexosephosphates metabolism MeSH
- Isoenzymes antagonists & inhibitors metabolism MeSH
- Catalysis MeSH
- Kinetics MeSH
- Oxygen pharmacology MeSH
- L-Lactate Dehydrogenase metabolism MeSH
- Mycobacterium tuberculosis drug effects enzymology MeSH
- Pyruvate Kinase metabolism MeSH
- Recombinant Proteins metabolism MeSH
- Substrate Specificity MeSH
- Feedback, Physiological MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
Tuberculosis (TB) remains one of the major health concerns worldwide. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can flexibly change its metabolic processes during different life stages. Regulation of key metabolic enzyme activities by intracellular conditions, allosteric inhibition or feedback control can effectively contribute to Mtb survival under different conditions. Phosphofructokinase (Pfk) is one of the key enzymes regulating glycolysis. Mtb encodes two Pfk isoenzymes, Pfk A/Rv3010c and Pfk B/Rv2029c, which are differently expressed upon transition to the hypoxia-induced non-replicating state of the bacteria. While pfkB gene and protein expression are upregulated under hypoxic conditions, Pfk A levels decrease. Here, we present biochemical characterization of both Pfk isoenzymes, revealing that Pfk A and Pfk B display different kinetic properties. Although the glycolytic activity of Pfk A is higher than that of Pfk B, it is markedly inhibited by an excess of both substrates (fructose-6-phosphate and ATP), reaction products (fructose-1,6-bisphosphate and ADP) and common metabolic allosteric regulators. In contrast, synthesis of fructose-1,6-bisphosphatase catalyzed by Pfk B is not regulated by higher levels of substrates, and metabolites. Importantly, we found that only Pfk B can catalyze the reverse gluconeogenic reaction. Pfk B thus can support glycolysis under conditions inhibiting Pfk A function.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019288
- 003
- CZ-PrNML
- 005
- 20210830100852.0
- 007
- ta
- 008
- 210728s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms22031483 $2 doi
- 035 __
- $a (PubMed)33540748
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Snášel, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 245 10
- $a Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation / $c J. Snášel, I. Machová, V. Šolínová, V. Kašička, M. Krečmerová, I. Pichová
- 520 9_
- $a Tuberculosis (TB) remains one of the major health concerns worldwide. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can flexibly change its metabolic processes during different life stages. Regulation of key metabolic enzyme activities by intracellular conditions, allosteric inhibition or feedback control can effectively contribute to Mtb survival under different conditions. Phosphofructokinase (Pfk) is one of the key enzymes regulating glycolysis. Mtb encodes two Pfk isoenzymes, Pfk A/Rv3010c and Pfk B/Rv2029c, which are differently expressed upon transition to the hypoxia-induced non-replicating state of the bacteria. While pfkB gene and protein expression are upregulated under hypoxic conditions, Pfk A levels decrease. Here, we present biochemical characterization of both Pfk isoenzymes, revealing that Pfk A and Pfk B display different kinetic properties. Although the glycolytic activity of Pfk A is higher than that of Pfk B, it is markedly inhibited by an excess of both substrates (fructose-6-phosphate and ATP), reaction products (fructose-1,6-bisphosphate and ADP) and common metabolic allosteric regulators. In contrast, synthesis of fructose-1,6-bisphosphatase catalyzed by Pfk B is not regulated by higher levels of substrates, and metabolites. Importantly, we found that only Pfk B can catalyze the reverse gluconeogenic reaction. Pfk B thus can support glycolysis under conditions inhibiting Pfk A function.
- 650 _2
- $a adenosindifosfát $x metabolismus $x farmakologie $7 D000244
- 650 _2
- $a adenosintrifosfát $x metabolismus $x farmakologie $7 D000255
- 650 _2
- $a alosterická regulace $7 D000494
- 650 _2
- $a bakteriální proteiny $x antagonisté a inhibitory $x metabolismus $7 D001426
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a enzymová indukce $7 D004790
- 650 _2
- $a zpětná vazba fyziologická $7 D025461
- 650 _2
- $a fruktosadifosfáty $x biosyntéza $x farmakologie $7 D005635
- 650 _2
- $a fruktosafosfáty $x metabolismus $x farmakologie $7 D005636
- 650 _2
- $a glukoneogeneze $7 D005943
- 650 _2
- $a glykolýza $7 D006019
- 650 _2
- $a hexosafosfáty $x metabolismus $7 D006600
- 650 _2
- $a izoenzymy $x antagonisté a inhibitory $x metabolismus $7 D007527
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a L-laktátdehydrogenasa $x metabolismus $7 D007770
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $x enzymologie $7 D009169
- 650 _2
- $a kyslík $x farmakologie $7 D010100
- 650 _2
- $a fosfofruktokinasy $x antagonisté a inhibitory $x metabolismus $7 D025221
- 650 _2
- $a pyruvátkinasa $x metabolismus $7 D011770
- 650 _2
- $a rekombinantní proteiny $x metabolismus $7 D011994
- 650 _2
- $a substrátová specifita $7 D013379
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Machová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Šolínová, Veronika $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Kašička, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Krečmerová, Marcela $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 700 1_
- $a Pichová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 3 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33540748 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100852 $b ABA008
- 999 __
- $a ok $b bmc $g 1690178 $s 1139734
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 3 $e 20210202 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a CZ.02.1.01/0.0/16_019/000729 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a RVO 61388963 $p Akademie Věd České Republiky
- LZP __
- $a Pubmed-20210728